Research Articles
Breaking the Cycle: How a Metabolic Protein Tames Lung Cancer Stem Cells and Fights Relapse
Discover how FBP1 protein inhibits non-small cell lung cancer stemness by promoting ubiquitination and degradation of Notch1 intracellular domain.
DNA-Damage Inducible 1: The Cellular Guardian Gone Rogue in Lung Cancer
Explore how DNA-Damage Inducible 1 (DDI1) contributes to therapy resistance in non-small cell lung cancer and its potential as a therapeutic target.
Shattering Cancer's Shield: The Revolutionary Bispecific Antibodies That Degrade c-MET in NSCLC
Discover how c-MET degrading bispecific antibodies (EpiTACs) are revolutionizing treatment for NSCLC and other c-MET driven tumors through targeted protein degradation.
UNBS1450: Nature's Answer to Lung Cancer's Defense System
How the plant-derived molecule UNBS1450 disrupts NF-κB signaling in non-small cell lung cancer cells, overcoming chemotherapy resistance.
BAP1: The Unsung Hero in Lung Cancer's Molecular Battlefield
Exploring BAP1's role as a prognostic biomarker and therapeutic target in non-small cell lung cancer (NSCLC)